Trial Profile
Prospective, Randomized 2 x 2 Factorial Trial of Rabbit Anti-thymocyte Globulin Induction (Single vs. Alternate Day Administration) at Renal Transplantation, With Delayed Calcineurin-inhibitor Withdrawal vs. Minimization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2023
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Mycophenolate mofetil; Sirolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 30 Aug 2023 Status changed from active, no longer recruiting to completed.
- 06 Jan 2010 Planned end date changed from Jun 2010 to Jun 2013 as reported by ClinicalTrials.gov.
- 20 Nov 2007 New trial record.